My recent article on the use of protective and confidentiality orders in the Federal Court is available on Slaw. This topic was one of the items discussed last week at the Federal Court town hall and was the subject of an order released last week which stated, “The open court principle is of crucial importance in a democratic society, … Confidentiality orders inherently compromise these fundamental principles and important rights.” Continue reading Protective Orders
Tag Archives: Read More
CETA
Bill C-30, the CETA implementation legislation received royal assent today. The Bill includes amendments to the Patent Act, regarding supplementary protection for pharmaceutical products and altering patent linkage system, and to the Trade-mark Act regarding geographic indicators with grounds of opposition and certain exceptions for prior use, acquired rights and generic terms. Amendments are also proposed to a number of other acts. Implementation regulations are expected any day.
CBA IP Day
After a kickoff at the Diversity Breakfast, CBA IP Day continued with the Federal Court’s Town Hall focused on the imminent overhaul to pharmaceutical litigation in Canada, including two years to trial, focused discovery, changes to costs regime and efficient trial management. Bill C-30, the CETA implementation legislation cleared the senate this afternoon. Continue reading CBA IP Day
Trial Management
The Federal Court issued a practice notice on trial management conferences and procedures. The guidelines identify issues to be determined at pre-trial conferences and trial management conferences as well as impose new deadlines for pre-trial steps.
Reasonable Royalties and Non-Infringing Alternatives
In a decision released earlier this year, Frac Shack Inc. v. AFD Petroleum Ltd., 2017 FC 104, the defendant was found to infringe several of the claims in a patent relating to a fuel delivery system used for hot refuelling equipment used for hydraulic fracturing. The court ordered a 27% royalty rate for sales made prior to the grant of the patent at issue and did not consider a manual process as being a non-infringing alternative. My article on this decision was published by Slaw. Continue reading Reasonable Royalties and Non-Infringing Alternatives
NAFTA
As mentioned on Friday, the NAFTA arbitration tribunal in the Eli Lilly ‘promise doctrine’ proceeding has issued a ruling. The public decision is now available confirming that the tribunal decided in favour of Canada on the merits. The decision addresses issues of jurisdiction, liability for judicial measures and Canada’s utility requirements for patents. Continue reading NAFTA
NAFTA
The NAFTA arbitration tribunal in the Eli Lilly ‘promise doctrine’ proceeding has issued a ruling. Reports are that the tribunal has decided in favour of Canada on the merits. Continue reading NAFTA
2016 in Official Marks
Canada has a scheme under the Trade-marks Act, where government authorities can list official marks. In 2016, over 700 prohibited marks were listed in Canada. The top ten filers were Continue reading 2016 in Official Marks
Canadian Trademark Firms in 2016
About 55,390 trademark applications were filed in Canada in 2016. Of these, about 24% were filed in-house or without an agent (up slightly from previous years). Check out my list of the 50 firms/agents that filed the most applications in 2016. Continue reading Canadian Trademark Firms in 2016
Fintech
Combining technology with financial services in the age of mobile, cloud and blockchain gives rise to many potential disruptors and established players trying to increase, protect, license and monetize their intellectual property. I explore some of these ideas in my recent article in Slaw on Protecting FinTech Innovation.
Continue reading Fintech